tirzepatide for obesity fda approval approves Zepbound (tirzepatide) as the first and only prescription medicine moderate-to-severe obstructive sleep apnea in adults with - Eli Lilly FDA approves Eli Lilly's Zepbound,

The latest: The digital health platform launched Body Scan, an AI-powered feature tracking muscle mass for GLP-1 users

The Chinese market for GLP-1 drugs, used to treat both obesity and diabetes, is expected to hit US$14 billion by 2030, according to L.E.K

This pharmaceutical-quality DERMIK formulation ensures the purity, sterility, and potency needed for professional non-invasive mesotherapy and advanced skin brightening treatmentsdelivering transformative lightening and anti-aging results that retail products simply cannot achieve

These products are labeled "Research Use Only" (RUO) and are intended for in-vitro laboratory research not human consumption